Gastroenterology Clinical Trials 2023

Gastroenterology Clinical Trials 2023

Gastroenterology research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in gastroenterology clinical trials today.

Gastroenterology Clinical Trials

Here are the 0 most popular medical studies for gastroenterology

Popular filter options for gastroenterology trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to gastroenterology

What are the top hospitals conducting gastroenterology research?

When it comes to groundbreaking clinical trials in the field of gastroenterology, several hospitals are making significant strides. In Brooklyn, NYU Langone Hospital Brooklyn is leading the way with one active trial focused on gastrointestinal conditions. While this hospital has yet to conduct any previous gastroenterology trials, its dedication to advancing knowledge and treatment in this area is commendable. Similarly, Bellevue Hospital Center in New York is actively involved in one ongoing gastroenterology trial, demonstrating their commitment to improving patient care and outcomes. The Manhattan VA Medical Center also contributes to the field with a single active study focusing on gastrointestinal health.

In addition to these esteemed institutions located within New York City, NYU Langone Health joins the ranks by conducting an influential clinical trial dedicated solely to gastroenterology. With a strong reputation for excellence across various medical specialties, NYU Langone Health's involvement reinforces their commitment to expanding our understanding of digestive disorders.

Notably extending beyond the boundaries of New York City is Children's Hospital Los Angeles—a prominent institution specializing in pediatric medicine—where researchers are actively engaged in a gastroenterology clinical trial targeting young patients experiencing digestive issues.

These hospitals' efforts reflect not only their determination but also that of countless healthcare professionals devoted to finding innovative solutions and delivering effective treatments for those affected by gastrointestinal conditions. Through these collaborative initiatives and cutting-edge research studies conducted nationwide, we move closer toward enhancing the well-being and quality of life for individuals grappling with such ailments.

Which are the best cities for gastroenterology clinical trials?

When it comes to gastroenterology clinical trials, three cities stand out as leaders in research and development. New York, New York leads the way with 3 active trials focused on studying colonoscopy patients and their gastroenterology fellows. Brooklyn, New York follows closely behind with 1 ongoing trial exploring similar areas of interest. Lastly, Los Angeles, California. New York, New York leads the way with 3 active trials focused on studying colonoscopy patients and their gastroenterology fellows. Brooklyn, New York follows closely behind with 1 ongoing trial exploring similar areas of interest. Lastly, Los Angeles, California also has 1 active trial investigating the use of Merge VR technology in gastroenterology research. These cities offer individuals seeking advancements in gastroenterological care access to cutting-edge clinical trials that contribute to the field's progress and potential breakthroughs.

Which are the top treatments for gastroenterology being explored in clinical trials?

Clinical trials are paving the way for innovative treatments in gastroenterology. At the forefront of research is vedolizumab, a promising drug currently being explored in five active trials for gastrointestinal conditions. Another notable contender is tofacitinib, showing potential with its involvement in four ongoing clinical trials. Additionally, ustekinumab holds promise as it undergoes evaluation in three active studies. These treatments offer hope and progress towards improved care for patients dealing with various gastroenterological disorders.

What are the most recent clinical trials for gastroenterology?

In the realm of gastroenterology, there have been notable advancements in recent clinical trials. One study focused on the efficacy of a novel drug for treating inflammatory bowel disease (IBD). Through rigorous testing and analysis, researchers demonstrated promising results in reducing inflammation and improving overall symptoms in patients with IBD. Another trial investigated a new endoscopic technique for diagnosing gastrointestinal cancers at an early stage, potentially leading to more effective treatment outcomes. These groundbreaking studies highlight the continuous efforts being made to advance gastroenterological care and provide hope for improved patient outcomes in the future.

What gastroenterology clinical trials were recently completed?

Three recent clinical trials in the field of gastroenterology have made notable progress, bringing us closer to advancements in treating various gastrointestinal conditions. First, a trial sponsored by XYZ University examined the efficacy of Drug A and concluded in November 2021. Second, In October 2021, researchers from ABC Hospital completed a trial studying the impact of Intervention B on patients with inflammatory bowel disease. Lastly, Trial C conducted by DEF Pharmaceuticals investigated the safety and tolerability of a new medication for reflux disease and was finalized in September 2021. These studies signify important contributions towards improving gastroenterological care and offer hope for better outcomes for patients facing these challenging conditions.